Learn More | This week's Fierce Biotech is brought to you by Aldevron.
Trouble viewing? Click here. |
Join us on October 6 at 11am ET to discover the benefits of Nanoplasmid, a next-generation plasmid.
Are you interested in higher yield and a better safety profile for your mRNA and AAV plasmid templates? Discover the Power of Small. The NanoplasmidTM platform is a next-generation small cloning backbone (<500) with a patented antibiotic-free selection system offering significant benefits in numerous cell and gene-based applications. |
| Nanoplasmid Benefits: Improved plasmid manufacturing (>1g/L) PolyA tail stabilization for mRNA production ITR repeat stabilization for AAV production Eliminates antibiotic resistance gene transfer Traditional plasmid retrofitting |
| Conventional mRNA expression vectors were compared to vectors retrofitted into the Nanoplasmid vector. For an AAV and other platform examples click here. Nanoplasmid, a next-generation plasmid, has been featured in many published studies and utilized in clinical trials. The Aldevron team can help you design and build a new construct or retrofit an existing traditional plasmid. |
|
| Want to reach 137,000+ Fierce Biotech subscribers with your own message?
Contact aalcover@questex.com or call 202-824-5074.
You are currently subscribed as newsletter@newslettercollector.com.
If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.
Questex, LLC
685 3rd Avenue, 21st Floor
New York, NY 10017 |
